FDA approves Pfizer booster for children as young as 12

The US Food and Drug Administration (FDA) approved use of the Pfizer booster for children as young as 12 years old on Monday.

The extra shot was recommended for children 12-15 years old if enough time has passed since their second dose.

Breaking News: The FDA cleared boosters of the Pfizer-BioNTech vaccine for 12- to 15-year-olds. The CDC is expected to sign off before shots are given out. https://t.co/LZo7bUwn50
— The New York Times (@nytimes) January 3, 2022

Final approval for this shot for younger teens is expected to come later this week from the Centers for Disease Control and Prevention (CDC).

The CDC also reduced the time needed to wait for a booster shot from six to five months as concerns grow over the spread of the Omicron variant.

Today, we took several actions as we amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine. https://t.co/2I8ItYEmfw pic.twitter.com/6ZWzIqawXj
— U.S. FDA (@US_FDA) January 3, 2022

Cat Grant

Catherine (Cat) Grant was a business-savvy media mogul who got her start working as a gossip columnist for the Daily Planet. Cat later became a gossip blogger and eventually the CEO of her own company, CatCo Worldwide Media, a multimedia entertainment and news conglomerate based out of National City. Years after her departure from CatCo, Cat has decided to take a cathartic journey back to her roots. Welcome back to Cat’s Corner.